Stock Market & Financial News
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
MRK Compared to Estimates, Valmont (VMI) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Valmont (VMI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
VMI Should You Invest in Vistra (VST) Based on Bullish Wall Street Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
VST General Motors (GM) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for General Motors (GM) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GM 
Hasbro (HAS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Hasbro (HAS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HAS 
Compared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metrics
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DHR 
Wall Street Bulls Look Optimistic About Newmont (NEM): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
NEM 
Compared to Estimates, Equifax (EFX) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Equifax (EFX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EFX 
Charles Schwab (SCHW) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Charles Schwab (SCHW) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SCHW 
Genuine Parts (GPC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Genuine Parts (GPC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GPC 
Here's What Key Metrics Tell Us About Northrop Grumman (NOC) Q2 Earnings
While the top- and bottom-line numbers for Northrop Grumman (NOC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
NOC 
Is Oracle (ORCL) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
ORCL 
Compared to Estimates, Mercantile Bank (MBWM) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Mercantile Bank (MBWM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MBWM 
Compared to Estimates, 3M (MMM) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for 3M (MMM) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MMM 
United Community Banks (UCB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for United Community Banks (UCB) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UCBJF 
MSCI (MSCI) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for MSCI (MSCI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MSCI 
Compared to Estimates, KeyCorp (KEY) Q2 Earnings: A Look at Key Metrics
The headline numbers for KeyCorp (KEY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
KEY 
Compared to Estimates, D.R. Horton (DHI) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for D.R. Horton (DHI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DHI 
This Is the Mag 7's Worst Performer Right Now. Can Q2 Change the Story?
Tesla (NASDAQ:TSLA | TSLA Price Prediction) heads into its Q2 2026 earnings report tomorrow as the undisputed laggard of the Magnificent 7.
TSLA 
ORIC Pharmaceuticals: Royalty-Free Phase 3 Economics Strengthen The Bull Case
ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights and royalty-free economics. ORIC's $419.7M cash position funds operations into 2H 2028, supporting pivotal trial readouts while minimizing dilution via strategic partnerships and disciplined capital allocation. Rinzimetostat's value is enhanced by a unique royalty-free license and free darolutamide supply from Bayer, maximizing potential post-approval returns.
ORIC 
Micron stock surges as banking giant names it one of the best stocks
Micron (NASDAQ: MU) stock surged around 8% to trade at $937 on Tuesday, July 21, as renewed bullish commentary from Wall Street analysts revived investor confidence in the memory chip sector.
MU 
Bets against SpaceX grow to 32% of float as Elon Musk warns short sellers won't survive
Elon Musk responded to the growing short interest in SpaceX, predicting investors betting against the company would ultimately lose. Short sellers boosted their wagers against the company to roughly 32% of its publicly tradable shares ahead of several key catalysts.
SPCX 
Bitcoin ETFs Extend Five‑Day Inflow Streak, Ethereum Funds Push Their Winning Run Higher
Bitcoin ETF Streak: Bitcoin ETFs recorded five straight days of inflows totaling about $727.3 million, with additional July 20 inflows of $181 million led by BlackRock's IBIT.
Ondo Perps Launches Tokenized Stock Collateral Feature
Ondo Finance has launched a tokenized stock collateral feature on Ondo Perps, letting traders post tokenized equities as margin for leveraged perpetual positions, beginning with the SPYon and QQQon tokens for Pre-Alpha users.
Can Nebius' $775M Debt Facility Accelerate Its Global AI Expansion?
NBIS secures a $775M debt facility backed by AI infrastructure and contracted cash flows, boosting capacity expansion while reducing equity reliance.
GTLL 
Washington Trust Bancorp, Inc. (WASH) Q2 2026 Earnings Call Transcript
Washington Trust Bancorp, Inc. (WASH) Q2 2026 Earnings Call Transcript
WASH 
Fiverr International: Worth A Shot With So Much Bad News Already Factored In
Fiverr is dealing with headwinds, and this is reflected in the much lower valuations than what has been the norm. AI is causing some users to leave the platform, but this does not mean growth is no longer possible in the age of AI. Growth is likely to return after a down year in FY2026, which suggests FVRR could be a bargain with where multiples are at.
FVRR 
These Dividend Aristocrats Yield Enough to Let Your Passive Income Do the Heavy Lifting
Dividend Aristocrats have earned their reputation the hard way: through recessions, rate cycles, and oil crashes, they kept raising the payout.
BEN 
SanDisk Rises 8%, Western Digital Jumps 9%, Micron Adds 7% as Memory Rebound Accelerates
Memory stocks are extending their rebound Tuesday morning, with SanDisk (NASDAQ:SNDK | SNDK Price Prediction) up 8% to $1,504, Western Digital (NASDAQ:WDC) up 9% to $531, and Micron Technology (NASDAQ:MU) up 7% to $923.
WDC 
Jito Unveils JTX: Professional-Grade DeFi Trading Platform for Solana Ecosystem
JTX debuts on Solana today, bringing professional trading capabilities and self-custodial features
